Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
PMLiVE
7h
Biogen’s higher dose spinal muscular atrophy regimen accepted for review by EMA/FDA
Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Fed holds rates steady
Rescinds freeze on grants
Los Angeles wildfire updates
Lay's potato chips recall
Ticks closer to catastrophe
Crowd crush at Kumbh Mela
FAA authorized NJ drones
Eagles fan dies
OK school citizenship rule
Approved for kidney disease
CO military base for ICE use
Denver schools face probe
To get own room in museum
Win special primary in FL
Announces deal with Visa
Pilot safe after F-35 crash
Sudden movement probe
Inspects nuclear facility
ICC sanctions bill blocked
Announces ChatGPT Gov
2023 derailment settlement
Security detail revoked
Email privacy lawsuit filed
Frontier makes second bid
Recalls chicken nuggets
Senate confirmation hearing
Consumer confidence dips
Related topics
Biogen
Food and Drug Administration
Spinal muscular atrophy
European Medicines Agency
Feedback